A 30-year-old daily wage worker from Tirupur walked into the KMCH in the end of April with a cactus like tumor protruding out of his right hip. The tumor which was noticed almost four years back, had been growing in size. The patient had approached few private hospitals but was turned away because they found it too risky.
Exostoses / Multiple Non-cancerous Bone Tumors - Causes, Symptoms, Diagnosis and Treatment
Hereditary multiple exostoses is a genetic disorder that causes skeletal abnormalities. Read on about its causes and symptoms and also how this symptom can be diagnosed and treated.
Hereditary multiple exostoses is a genetic disorder that causes skeletal abnormalities. Read on about its causes and symptoms and also how this symptom can be diagnosed and treated.
Osteochondroma is a genetically transmitted non-cancerous bone tumor, usually present around the knee joint area.
Doctors performed a four-hour long surgery called type 1 Internal hemipelvectomy, a major portion of the hip bone was removed from the lower part of the spine.
Therapy That Destroys Bone Tumors Eases Pain
Cancer patients that has spread to their bones are often treated with radiation therapy to reduce pain. But if that treatment doesn't work, or can't be used again, a second, effective option now exists.
Cancer patients that has spread to their bones are often treated with radiation therapy to reduce pain. But if that treatment doesn't work, or can't be used again, a second, effective option now exists.
Source-Medindia
Scientists Discover 2 Types of Bone Tumor Defined By Novel Mutations
A rare discovery was made by scientists that allows them to attribute two types of tumour almost entirely to specific mutations that lie in two related genes.
A rare discovery was made by scientists that allows them to attribute two types of tumour almost entirely to specific mutations that lie in two related genes.
In 90 Percent Of Most Common Childhood Bone Tumor, TP53-Tumor Suppressor Gene Mutated
The tumor suppressant gene TP53 has been found to be mutated in 90 percent of osteocarcomas, suggesting gene alteration plays a key role in early development of cancer, found by researchers.
The tumor suppressant gene TP53 has been found to be mutated in 90 percent of osteocarcomas, suggesting gene alteration plays a key role in early development of cancer, found by researchers.
